Today, every tenth Life Sciences company in Europe is Finnish. The Finnish LifeSciences or biotechnological industry is ranked sixth in the European context. The strength areas of Finland in biotechnology are pharmaceuticals, bio-materials, diagnostics, and industrial enzymes.

France allocates 7% of its GDP to education, 9% to healthcare and 2% to research. Over the last twenty years, France has become a major player in the European biotechnology sector.

A large part of India’s attractiveness stems from the sheer size of its demographics. According to estimates 65 percent of the market is virtually untapped because the current infrastructure is good only to reach 30 to 35 percent of the population. While the future looks bright, the challenges remain varied. From lack of clarity in terms of what is patentable, to infrastructure and policy issues, the journey to success is fraught with obstacles. Understand India, With an Atharva GloLife report!

Israel is home to a thriving Life Sciences industry in which the major sectors are Medical Devices and BioPharma. Over the last 5 years,more companies were established in life sciences than in any other sector, with the rate of investments (including Angels, Venture Capital and Corporate) greatly outpacing all other segments of the economy. Explore lifesciences in Israel with an Atharva Lifesciences report! Shalom!

Malaysia aspires to be a biotechnology hub and this is clearly spelled out in the National Biotechnology Policy that was launched on the 28th April 2005. It is estimated that by 2020, this sector would create 280,000 jobs and contribute five per cent to the country’s Gross Domestic Product. Explore Lifesciences in Malaysia with a Atharva GloLife Report!

The Dutch ‘red’ biotech sector, is rising higher in the international rankings of the top clusters. A large number of companies in the Netherlands are active in this sector and the number of private investments by venture capitalists are increasing. The Netherlands is home to multiple partnerships in biotechnology in which the public and private sector work together towards a bio-based economy by translating knowledge into innovation. Public parties work on disciplines like microbial genomics, catalysis and process technology. Understand the Dutch, with a Atharva GloLife Report!

New Zealand has one of the fastest growing biotech industries the world. Apart from BioPharma, New Zealand’s geographic isolation and strict quarantine standards contribute to the best animal health rating in the world, uniquely positioning the country as a global leader in agricultural biotechnology research and application.

Russia is advancing rapidly. It recently successfully completed the first stage of clinical trials of an HIV vaccine. The State Research Center for Virology and Biotechnology, Vektor, completed the first stage of clinical trials of the HIV vaccine. Discover Lifesciences in Russia with a Atharva GloLife report!

Spain has a long tradition of scientific excellence, particularly in the life sciences.In the past decade the country has focused on transforming its research into consumer-focused companies and products. Understand Spain. With an Atharva GloLife Report!

Economically, reports show that Thailand will be the eighth largest economy in the Asia Pacific region by 2016. Real GDP growth is projected to increase in the forecast period, reaching 7.1% by 2016. Demographically, the EIU projects an annual growth rate of around 0.7% and the population to be the ninth largest in the Asia Pacific region by 2016. The elderly population is rising; Thailand is expected to have the eighth highest proportion in the Asia Pacific region.

The UK life sciences market is among the strongest and fastest-growing in the world. Biotechnology, healthcare and pharmaceutical industries in the UK have an outstanding track record in drug discovery, a strong academic base and increasing Government support for R&D through investment and tax credits.